Back to VRDN

Bellevue Group AG → VRDN

Bellevue Group AG VRDN Position History

Viridian Therapeutics, Inc. • Healthcare

Quarters held
8
Latest value
$146.3M
Q3 2026
Peak value
$146.3M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$87K
Q4 2025$135.6M
Q1 2026$169K
Q1 2026$131.4M
Q2 2026$264K
Q2 2026$123.4M
Q3 2026$80K
Q3 2026$146.3M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$146.3M7.11M——
Q3 2026$80K3.9K——
Q2 2026$123.4M6.72M——
Q2 2026$264K14.4K——
Q1 2026$131.4M6.72M——
Q1 2026$169K8.6K——
Q4 2025$135.6M4.36M——
Q4 2025$87K2.8K——

Other funds holding VRDN

Other Bellevue Group AG positions

RVMDW

REVOLUTION MEDICINES INC

$398.3M
ARGX

ARGENX SE

$386M
IONS

IONIS PHARMACEUTICALS INC

$377.7M
AMGN

AMGEN INC

$350.5M
GILD

GILEAD SCIENCES INC

$312M
VRTX

VERTEX PHARMACEUTICALS INC

$302.6M
AMGN

AMGEN INC

$301.1M
VRTX

VERTEX PHARMACEUTICALS INC

$298M